Carole Devaux

Latest publications

Determinants of HIV-1 late presentation in patients followed in Europe.

  • HIV Clinical and Translational Research
July 02, 2021
2021 Jul. Pathogens.10(7):835.
By:
  • Miranda MNS
  • Pingarilho M
  • Pimentel V
  • Martins MdRO
  • Vandamme A-M
  • Bobkova M
  • Böhm M
  • Seguin-Devaux C
  • Paredes R
  • Rubio R
  • Zazzi M
  • Incardona F
  • Abecasis A.

Effectiveness of integrase strand transfer inhibitor-based regimens in HIV-infected treatment-naive individuals: results from a European multi-cohort study.

  • HIV Clinical and Translational Research
July 02, 2021
2021 Jul. J Antimicrob Chemother. Online ahead of print.
By:
  • Rossetti B
  • Fabbiani M
  • Di Carlo D
  • Incardona F
  • Abecasis A
  • Gomes P
  • Geretti AM
  • Seguin-Devaux C
  • Garcia F
  • Kaiser R
  • Modica S
  • Shallvari A
  • Sonnerborg A
  • Zazzi M
  • EuResist Network Integrate study group.

Validation of molecular clock inferred HIV infection ages: Evidence for accurate estimation of infection dates.

  • HIV Clinical and Translational Research
July 01, 2021
2021 Jul. Infect Genet Evol.91:104799. Epub 2021 Mar 4.
By:
  • Kostaki EG
  • Limnaios S
  • Roussos S
  • Psichogiou M
  • Nikolopoulos GK
  • Friedman SR
  • Antoniadou A
  • Chini M
  • Hatzakis A
  • Sypsa V
  • Magiorkinis G
  • Seguin-Devaux C
  • Paraskevis D.

Active components from Cassia abbreviata prevent HIV-1 entry by distinct mechanisms of action.

  • HIV Clinical and Translational Research
  • Immuno-Pharmacology and Interactomics
May 10, 2021
2021 May. Int J Mol Sci.22(9):5052.
By:
  • Zheng Y
  • Yang XW
  • Schols D
  • Mori M
  • Botta B
  • Chevigne A
  • Mulinge M
  • Steinmetz A
  • Schmit JC
  • Seguin-Devaux C.

Chemical constituents of Cassia abbreviata and their anti-HIV-1 activity.

  • HIV Clinical and Translational Research
April 23, 2021
2021 Apr. Molecules.26(9).
By:
  • Yang X
  • He Z
  • Zheng Y
  • Wang N
  • Mulinge M
  • Schmit JC
  • Steinmetz A
  • Seguin-Devaux C.

Cytotoxic CD8+ T Cells expressing CXCR5 are detectable in HIV-1 elite controllers after prolonged in vitro peptide stimulation.

  • HIV Clinical and Translational Research
February 24, 2021
2021 Feb. Front Immunol.11:622343.
By:
  • Adams P
  • Iserentant G
  • Servais JY
  • Vandekerckhove L
  • Vanham G
  • Seguin-Devaux C
  • PhenoCure Study G.

CD32(+)CD4(+) memory T cells are enriched for total HIV-1 DNA in tissues from humanized mice.

  • HIV Clinical and Translational Research
  • Platform National Cytometry
January 22, 2021
2021 Jan. iScience.24(1):101881.
By:
  • Adams P
  • Fievez V
  • Schober R
  • Amand M
  • Iserentant G
  • Rutsaert S
  • Dessilly G
  • Vanham G
  • Hedin F
  • Cosma A
  • Moutschen M
  • Vandekerckhove L
  • Seguin-Devaux C.

Molecular epidemiological analysis of the origin and transmission dynamics of the HIV-1 CRF01_AE sub-epidemic in Bulgaria.

  • HIV Clinical and Translational Research
January 16, 2021
2021 Jan. Viruses.13(1):116.
By:
  • Alexiev I
  • Campbell EM
  • Knyazev S
  • Pan Y
  • Grigorova L
  • Dimitrova R
  • Partsuneva A
  • Gancheva A
  • Kostadinova A
  • Seguin-Devaux C
  • Elenkov I
  • Yancheva N
  • Switzer WM.

Could the COVID-19 crisis help eradicate chronic homelessness?

  • HIV Clinical and Translational Research
January 01, 2021
2021 Jan. Am J Public Health.111(1):25-26.
By:
  • Wiessing LG
  • Seguin-Devaux C
  • Merendeiro CS.

The case for simplifying and using absolute targets for viral hepatitis elimination goals.

  • HIV Clinical and Translational Research
January 01, 2021
2021 Jan. J Viral Hepat.28(1):12-19. Epub 2020 Nov 4.
By:
  • Polaris Observatory Collaborators (Devaux C. as LIH collaborator).

HIV/AIDS surveillance in Europe 2020 (2019 data). (Book)

  • HIV Clinical and Translational Research
November 26, 2020
2020 Nov. Copenhagen: WHO Regional Office for Europe, 2020. 113 p. ISBN; 978-92-9498-527-9 (EDC PDF); 978-92-8905a-534-5 (WHO).
By:
  • European Centre for Disease Prevention and Control
  • WHO Regional Office for Europe
  • Devaux C. (as contributor for HIV/AIDS surveillance at Luxembourg).

Combination disease prevention in prisons: a comprehensive programme in Luxembourg. In Compendium of good practices in the health sector response to viral hepatitis in the WHO European Region. (Book Chapter)

  • HIV Clinical and Translational Research
  • Clinical and Epidemiological Investigation Center
July 27, 2020
2020 Jul. Copenhagen: WHO Regional Office for Europe, 2020. p.50-53. ISBN 9289055162.
By:
  • Hoffmann P
  • Arendt V
  • Fischer A
  • Menster M
  • Etienne V
  • Meyers J
  • Conrath M
  • Stein R
  • Braunert C
  • Foulon M-L
  • Seguin-Devaux C.

HIV outbreaks among people who inject drugs in Europe, North America, and Israel.

  • HIV Clinical and Translational Research
June 01, 2020
2020 Jun. Lancet HIV.7(6):e434-e442.
By:
  • Des Jarlais DC
  • Sypsa V
  • Feelemyer J
  • Abagiu AO
  • Arendt V
  • Broz D
  • Chemtob D
  • Seguin-Devaux C
  • Duwve JM
  • Fitzgerald M
  • Goldberg DJ
  • Hatzakis A
  • Jipa RE
  • Katchman E
  • Keenan E
  • Khan I
  • Konrad S
  • McAuley A
  • Skinner S
  • Wiessing L.

A class of potent Inhibitors of the HIV-1 nucleocapsid protein based on aminopyrrolic scaffolds.

  • HIV Clinical and Translational Research
May 14, 2020
2020 May. ACS Med Chem Lett.11(5):698-705.
By:
  • Ciaco S
  • Humbert N
  • Real E
  • Boudier C
  • Francesconi O
  • Roelens S
  • Nativi C
  • Seguin-Devaux C
  • Mori M
  • Mely Y.

Drug-related infectious diseases in Europe. Update from the EMCDDA expert network, 2020. (Book)

  • HIV Clinical and Translational Research
May 01, 2020
2020 May. Luxembourg: Publications Office of the European Union, 2020. 27 p. (Technical report). ISBN 978-92-9497-492-1.
By:
  • EMCDDA expert network (Devaux C. as collaborator for DRID network).

Molecular epidemiology of the HIV-1 subtype B sub-epidemic in Bulgaria.

  • HIV Clinical and Translational Research
April 14, 2020
2020 Apr. Viruses.12(4):441.
By:
  • Alexiev I
  • Campbell EM
  • Knyazev S
  • Pan Y
  • Grigorova L
  • Dimitrova R
  • Partsuneva A
  • Gancheva A
  • Kostadinova A
  • Seguin-Devaux C
  • Switzer WM.

(Thia)calixarenephosphonic acids as potent inhibitors of the nucleic acid chaperone activity of the HIV-1 nucleocapsid protein with a new binding mode and multi-target antiviral activity.

  • HIV Clinical and Translational Research
April 10, 2020
2020 Apr. ACS Infect Dis.6(4):687-702. Epub 2020 Feb 21.
By:
  • Humbert N
  • Kovalenko L
  • Saladini F
  • Giannini A
  • Pires M
  • Botzanowski T
  • Cherenok S
  • Boudier C
  • Sharma KK
  • Real E
  • Zaporozhets OA
  • Cianferani S
  • Seguin-Devaux C
  • Poggialini F
  • Botta M
  • Zazzi M
  • Kalchenko VI
  • Mori M
  • Mely Y.

Less cytotoxic protoflavones as antiviral agents: Protoapigenone 1′-O-isopropyl Ether shows improved selectivity against the Epstein-Barr Virus lytic cycle.

  • HIV Clinical and Translational Research
December 04, 2019
2019 Dec. Int J Mol Sci.20(24):6269.
By:
  • Vagvolgyi M
  • Girst G
  • Kusz N
  • Otvos SB
  • Fulop F
  • Hohmann J
  • Servais JY
  • Seguin-Devaux C
  • Chang FR
  • Chen MS
  • Chang LK
  • Hunyadi A.

Combattre l’hépatite C chez les usagers de drogues injectables au Luxembourg : illustration d’une approche intersectorielle.

  • HIV Clinical and Translational Research
December 01, 2019
2019 Dec. Addiction(s) : recherches et pratiques.(4):22-25.
By:
  • Berndt N
  • Devaux C
  • Seixas R.

Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface.

  • HIV Clinical and Translational Research
  • Platform National Cytometry
  • Immuno-Pharmacology and Interactomics
September 01, 2019
2019 Sep. J Int AIDS Soc.22(9):e25384.
By:
  • Arendt V
  • Amand M
  • Iserentant G
  • Lemaire M
  • Masquelier C
  • Ndayisaba GF
  • Verhofstede C
  • Karita E
  • Allen S
  • Chevigne A
  • Schmit JC
  • Bercoff DP
  • Seguin-Devaux C.